Status:
COMPLETED
Evaluation of the Pharmacokinetic Interaction Between Candesartan and Felodipine After Ingestion of a Specific Meal
Lead Sponsor:
AstraZeneca
Collaborating Sponsors:
Scentryphar Clinical Research
Cori Analyticals
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate the pharmacokinetic interaction of test formulations of candesartan and felodipine in a combination package comparing with the fasting intake of commercial for...
Eligibility Criteria
Inclusion
- Healthy volunteers
- BMI \> or = 19 and \< or = 28 (Dietary Guidelines Advisory Committee, 2005)
Exclusion
- Not healthy
- Chronic drug intake
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00905333
Start Date
October 1 2008
End Date
November 1 2008
Last Update
December 7 2010
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Itatiba, São Paulo, Brazil
2
Research Site
Americana, Brazil